AEPCX
Price
$57.74
Change
-$0.23 (-0.40%)
Updated
Jun 3 closing price
Net Assets
133.25B
FAOAX
Price
$36.60
Change
-$0.21 (-0.57%)
Updated
Jun 3 closing price
Net Assets
453.66M
Interact to see
Advertisement

AEPCX vs FAOAX

Header iconAEPCX vs FAOAX Comparison
Open Charts AEPCX vs FAOAXBanner chart's image
American Funds Europacific Growth C
Price$57.74
Change-$0.23 (-0.40%)
VolumeN/A
Net Assets133.25B
Fidelity Advisor Overseas A
Price$36.60
Change-$0.21 (-0.57%)
VolumeN/A
Net Assets453.66M
AEPCX vs FAOAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FAOAX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and FAOAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FAOAX (454M). FAOAX pays higher dividends than AEPCX: FAOAX (1.14) vs AEPCX (0.32). AEPCX was incepted earlier than FAOAX: AEPCX (24 years) vs FAOAX (29 years). AEPCX (1.59) is less costly to investors than FAOAX (1.05). FAOAX is a more actively managed with annual turnover of: 34.00 vs. AEPCX (30.00). FAOAX has a lower initial minimum investment than AEPCX: FAOAX (0) vs AEPCX (250). FAOAX annual gain was more profitable for investors over the last year : 13.94 vs. AEPCX (1.80). FAOAX return over 5 years is better than : 55.38 vs. AEPCX (15.20).
AEPCXFAOAXAEPCX / FAOAX
Total Expense Ratio1.591.05151%
Annual Report Gross Expense Ratio1.591.05151%
Fund Existence24 years29 years-
Gain YTD11.74817.71766%
Front LoadN/A6%-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B454M29,295%
Annual Yield % from dividends0.321.1428%
Returns for 1 year1.8013.9413%
Returns for 3 years14.7240.9736%
Returns for 5 years15.2055.3827%
Returns for 10 years19.4467.0129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELTX8.080.33
+4.26%
Elicio Therapeutics
MBC10.200.38
+3.87%
MasterBrand
IOVA1.820.06
+3.41%
Iovance Biotherapeutics
VIVS1.770.02
+1.43%
VivoSim Lab Inc
SNN29.12-0.03
-0.10%
Smith & Nephew plc